# SUNITINIB MALATE
> **ANDA218024** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA · Approved 2023-10-24
## Drug
- **FDA Application Number:** ANDA218024
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUNITINIB MALATE
- **Generic name:** Sunitinib Malate
- **Active ingredients:** SUNITINIB MALATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NATCO PHARMA
- **First approval:** 2023-10-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218024)
---
*AI Analytics · CC0 1.0*